Skip to main navigation Skip to search Skip to main content

Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial

Research output: Contribution to journalArticle

Abstract

To evaluate the long-term effects of drospirenone (DRSP)/ethinylestradiol (EE) alone, metformin alone, and DRSP/EE-metformin on CD4(+)CD28(null) T lymphocytes frequency, a cardiovascular risk marker, in patients with hyperinsulinemic polycystic ovary syndrome (PCOS).
Original languageEnglish
Pages (from-to)1508-1517
Number of pages10
JournalReproductive Sciences
Volume20
Issue number12
DOIs
Publication statusPublished - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynaecology

Keywords

  • Adolescent
  • Adult
  • Analysis of Variance
  • Androstenes
  • Antigens
  • CD28
  • CD4 Lymphocyte Count
  • CD4+CD28null T-lymphocytes
  • CD4-Positive T-Lymphocytes
  • Cardiovascular Diseases
  • Chi-Square Distribution
  • Ethinyl Estradiol
  • Female
  • Humans
  • Hyperinsulinism
  • Hypoglycemic Agents
  • Metformin
  • Polycystic Ovary Syndrome
  • Reproductive Control Agents
  • Risk Factors
  • Rome
  • Time Factors
  • Treatment Outcome
  • Young Adult
  • drospirenone
  • ethinylestradiol
  • metformin
  • polycystic ovary syndrome

Fingerprint

Dive into the research topics of 'Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial'. Together they form a unique fingerprint.

Cite this